Earnings Call · Q1 FY2022·2022-05-07

Q1 22EPS -38.46%·Rev n/aQ4 21EPS -26.19%·Rev n/aQ3 21EPS +30.16%·Rev n/aQ2 21EPS +20.78%·Rev n/a⚠ consensus missing

Kiniksa Pharmaceuticals International, plc KNSA

Rachel Frank — Investor Relations

Sanj Patel — Chief Executive Officer

Ross Moat — Chief Commercial Officer

Mark Ragosa — Chief Financial Officer

+7.4%1d on move date+7.0% vs SPY3d−1.4%5d−16.0%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more KNSA calls or request research access.

More KNSA calls Browse calls Request research access